Escape from gammaherpesvirus-induced mRNA destruction

逃避伽马疱疹病毒诱导的 mRNA 破坏

基本信息

  • 批准号:
    8309954
  • 负责人:
  • 金额:
    $ 31.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-08-01 至 2016-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) are major causes of cancers in immunocompromised individuals. In the case of KSHV, infection rates in sub-Saharan Africa can approach 80% and, as a result, the incidence there of Kaposi's sarcoma is rising and it is emerging as one of the most common adult malignancies. These large double stranded DNA viruses are amplified during lytic replication, but persist for the lifetime of their host in a nonreplicative, latent state. While tumorigenesis is predominantly associated with the latent form of the virus, for KSHV latency is generally not a transforming event and KSHV-induced diseases also require low-level, ongoing lytic replication. Lytic replication is necessary both as a source of new virus to infect naive cells, and to drive production of viral and host paracrine factors that enhance growth of latently infected cells and create an appropriate tumor microenvironment. However, one prominent phenotype occurring during lytic gammaherpesvirus infection is the widespread destruction of cellular messenger RNA (mRNA), which potently inhibits host gene expression. Thus, there is a paradox between the necessity for lytically infected cells to induce specific host genes and the concomitant block in cellular gene expression. The goal of this project is to determine mechanistically how specific host genes evade destruction. Degradation of mRNA during lytic infection is orchestrated by the viral SOX protein, which coordinates with cellular RNA turnover factors to execute shutoff of gene expression. Interestingly, we have observed that select messages such as interleukin-6 (IL-6) are directly refractory to SOX-induced turnover. In the case of IL-6, we have mapped a cis-acting escape element to a region of its 3' untranslated region, and identified several host proteins that complex with this RNA element. One aspect of the project is therefore to explore the mechanistic consequences of these RNA-protein interactions, and determine how they influence IL-6 mRNA stability in the presence and absence of SOX. Given the numerous roles for IL-6 in human disease, this information will be relevant both to KSHV-induced neoplasms as well as potential dysregulation of this cytokine in other cancers. We will then broaden our focus to explore potentially conserved mechanisms of escape, using genome-wide data sets obtained from microarray and deep sequencing analyses. We anticipate these studies may reveal novel pathways that control message fate, and how manipulation of such pathways contributes to both infectious and genetic diseases.
描述(由申请人提供):卡波西伽马比病毒与肉瘤相关的疱疹病毒(KSHV)和爱泼斯坦 - 巴尔病毒(EBV)是免疫强化个体中癌症的主要原因。就KSHV而言,撒哈拉以南非洲的感染率可以接近80%,因此,卡波西肉瘤的发病率正在上升,并且正在成为最常见的成人恶性肿瘤之一。这些大的双链DNA病毒在裂解复制过程中被放大,但在其宿主的寿命中持续存在,处于非重复性的潜在状态。虽然肿瘤发生主要与病毒的潜在形式相关,但由于KSHV潜伏期通常不是转化的事件,而KSHV诱导的疾病也需要低级,持续的裂解复制。裂解复制既是感染幼稚细胞的新病毒的来源,又是驱动病毒和宿主旁分泌因子的产生,从而增强了潜在感染细胞的生长并创建适当的肿瘤微环境。然而,在裂解γ瘤病毒感染期间发生的一种突出的表型是细胞信使RNA(mRNA)的广泛破坏,它有效地抑制了宿主基因的表达。因此,在细胞中诱导特定宿主基因的必要性与细胞基因表达中的伴随障碍物之间存在悖论。该项目的目的是从机械上确定特定的宿主基因逃避破坏的方式。裂解感染过程中mRNA的降解是由病毒sox蛋白策划的,该病毒蛋白与细胞RNA周转因子协调以执行基因表达的关闭。有趣的是,我们已经观察到,诸如白介素6(IL-6)之类的精选消息直接难治于SOX诱导的营业额。在IL-6的情况下,我们已将顺式作用逃逸元件映射到其3'未翻译区域的区域,并确定了几种与该RNA元素复杂的宿主蛋白。因此,该项目的一个方面是探索这些RNA蛋白质相互作用的机械后果,并确定它们在存在和不存在SOX的情况下如何影响IL-6 mRNA稳定性。鉴于IL-6在人类疾病中的作用众多,该信息将与KSHV诱导的肿瘤以及该细胞因子在其他癌症中的潜在失调有关。然后,我们将使用从微阵列和深层测序分析获得的全基因组数据集探索逃生的潜在保守机制。我们预计这些研究可能会揭示控制信息命运的新途径,以及对这种途径的操纵如何促进感染和遗传疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Britt A Glaunsinger其他文献

Britt A Glaunsinger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Britt A Glaunsinger', 18)}}的其他基金

2023 Viruses and Cells Gordon Research Conference and Gordon Research Seminar
2023病毒与细胞戈登研究大会暨戈登研究研讨会
  • 批准号:
    10609208
  • 财政年份:
    2023
  • 资助金额:
    $ 31.16万
  • 项目类别:
Functional Characterization of Herpesvirus-Activated Noncoding Retrotransposon RNAs
疱疹病毒激活的非编码反转录转座子 RNA 的功能表征
  • 批准号:
    9975697
  • 财政年份:
    2019
  • 资助金额:
    $ 31.16万
  • 项目类别:
Regulation of Gammaherpesviral Late Gene Expression
γ疱疹病毒晚期基因表达的调控
  • 批准号:
    10368981
  • 财政年份:
    2015
  • 资助金额:
    $ 31.16万
  • 项目类别:
Regulation of Gammaherpesviral Late Gene Expression
γ疱疹病毒晚期基因表达的调控
  • 批准号:
    9178643
  • 财政年份:
    2015
  • 资助金额:
    $ 31.16万
  • 项目类别:
Regulation of Gammaherpesviral Late Gene Expression
γ疱疹病毒晚期基因表达的调控
  • 批准号:
    10223851
  • 财政年份:
    2015
  • 资助金额:
    $ 31.16万
  • 项目类别:
Regulation of Gammaherpesviral Late Gene Expression
γ疱疹病毒晚期基因表达的调控
  • 批准号:
    9049040
  • 财政年份:
    2015
  • 资助金额:
    $ 31.16万
  • 项目类别:
Disruption of Cellular RNA Processing by Kaposi's Sarcoma-Associated Herpesvirus
卡波西肉瘤相关疱疹病毒对细胞 RNA 加工的破坏
  • 批准号:
    9317435
  • 财政年份:
    2015
  • 资助金额:
    $ 31.16万
  • 项目类别:
Regulation of Gammaherpesviral Late Gene Expression
γ疱疹病毒晚期基因表达的调控
  • 批准号:
    10576837
  • 财政年份:
    2015
  • 资助金额:
    $ 31.16万
  • 项目类别:
Escape from gammaherpesvirus-induced mRNA destruction
逃避伽马疱疹病毒诱导的 mRNA 破坏
  • 批准号:
    8148069
  • 财政年份:
    2011
  • 资助金额:
    $ 31.16万
  • 项目类别:
Escape from gammaherpesvirus-induced mRNA destruction
逃避伽马疱疹病毒诱导的 mRNA 破坏
  • 批准号:
    8459030
  • 财政年份:
    2011
  • 资助金额:
    $ 31.16万
  • 项目类别:

相似海外基金

The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
  • 批准号:
    10752274
  • 财政年份:
    2024
  • 资助金额:
    $ 31.16万
  • 项目类别:
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
  • 批准号:
    10817516
  • 财政年份:
    2023
  • 资助金额:
    $ 31.16万
  • 项目类别:
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
  • 批准号:
    10750357
  • 财政年份:
    2023
  • 资助金额:
    $ 31.16万
  • 项目类别:
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
了解淋巴瘤对蛋白精氨酸甲基转移酶抑制剂的耐药机制
  • 批准号:
    10668754
  • 财政年份:
    2023
  • 资助金额:
    $ 31.16万
  • 项目类别:
Potentials of Epigenetic Molecules in Attenuating the Phenotypes of Periodontitis
表观遗传分子减轻牙周炎表型的潜力
  • 批准号:
    10736171
  • 财政年份:
    2023
  • 资助金额:
    $ 31.16万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了